Clinical Trials Browser

Phase 3 × Rivaroxaban × Plasma cell × Clear all

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism